Crossmark

Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab

Crossref DOI link: https://doi.org/10.1007/s12185-020-02989-5

Published Online: 2020-09-04

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tomuleasa, Ciprian https://orcid.org/0000-0001-5500-1519
Iluta, Sabina

Pasca, Sergiu

Roman, Andrei

Piciu, Doina

Jitaru, Ciprian

Teodorescu, Patric

Rus, Ioana

Bojan, Anca

Dima, Delia

Zdrenghea, Mihnea

Petrushev, Bobe
License Information

Text and Data Mining valid from 2020-09-04

Version of Record valid from 2020-09-04
More Information

Article History

Received: 1 July 2020

Accepted: 27 August 2020

First Online: 4 September 2020

Compliance with ethical standards

:

: The authors report no conflicts of interest.

Document is current

Any future updates will be listed below